<ѻý>Studies Make Case for Hormonal Therapy in nmCRPCѻý> Prolonged survival with three different androgen signaling inhibitors May 30, 2020
<ѻý>HCQ Linked to Harm in Cancer Patientsѻý> Combination with azithromycin associated with three-fold risk of mortality, registry study shows May 28, 2020
<ѻý>New First-Line Standard in Metastatic Bladder Cancerѻý> "High bar to beat" as avelumab maintenance improves median survival by over 7 months May 28, 2020
<ѻý>Paradigm Shift Coming for Early NSCLC?ѻý> Postoperative osimertinib doubles DFS in patients with stages Ib-IIIa EGFR+ lung cancer May 28, 2020
<ѻý>End of Life and COVID-19; DCIS Doubles Cancer Risk; Training for 'Bad News'ѻý> News, features, and commentary about cancer-related issues May 28, 2020
<ѻý>New Clue to Anti-PD-L1 Activity in Breast Cancer?ѻý> Survival benefit with durvalumab in patients with PDL1 copy number alteration May 26, 2020
<ѻý>Biologics Don't Increase Melanoma Risk... Probablyѻý> Meta-analysis offers some reassurance, but leaves room for doubt May 20, 2020
<ѻý>Avelumab Flops Again in Ovarian Cancerѻý> Another negative phase III trial, now in the first-line setting May 19, 2020
<ѻý>PARP Inhibitors Still Work in HRD-Low Ovarian Cancerѻý> In VELIA, homologous recombination deficiency score prognostic but not predictive May 14, 2020
<ѻý>KRAS May Predict Benefit of MEK Inhibitors in Some Ovarian Cancersѻý> Nearly 7-month PFS boost in patients with KRAS mutations May 11, 2020
<ѻý>Five Days of G-CSF Adequate for Breast Cancer Chemoѻý> Rate of chemotherapy-induced febrile neutropenia similar to 7- to 10-day regimen May 08, 2020
<ѻý>Face-Aging Selfies Help Modify Risky Skin Behaviors for Teensѻý> Trial looked at effects of a free "UV-selfie" app May 07, 2020
<ѻý>BMI, Weight Change Linked to Prostate Ca Outcomesѻý> Gain or loss of body weight both show risk May 07, 2020
<ѻý>Blood Test Promising as Colorectal Cancer Screenѻý> In early study, better numbers than with current alternatives to colonoscopy May 07, 2020
<ѻý>Ranitidine Cancer Risk: Health Records Offer Reassuranceѻý> Huge study finds no indication that nitrosamine contamination affected real-world outcomes May 05, 2020
<ѻý>Honing Chemo Use in Small Breast Tumorsѻý> Clearest survival benefit for 8-10 mm tumors in HR/HER2-positive disease May 03, 2020
<ѻý>Nivolumab-Based Tx Effective in Early, Unfavorable Hodgkin'sѻý> Interim results showed high CR rates and almost 100% PFS, OS at 12 months May 01, 2020
<ѻý>6-Week Keytruda Safe, Effective in Melanomaѻý> Schedule gets FDA approval for all adult indications Apr 30, 2020
<ѻý>Talzenna Misses OS Endpoint in BRCA-Positive Breast Cancerѻý> But PARP inhibitor improved patient-reported outcomes over standard therapy Apr 29, 2020
<ѻý>COVID-19 Mortality Spikes in Patients With Lung, Blood Cancersѻý> Those with metastatic disease also at special risk for poor outcomes Apr 28, 2020
<ѻý>Anti-PD-L1 Plus PARP Inhibitor Ups Response in Breast Cancerѻý> Add-on treatment superior to chemo alone, but questions remain about cost, toxicity Apr 28, 2020
<ѻý>Triplet Succeeds in BRAF-Mutant Melanomaѻý> Immunotherapy plus BRAF/MEK inhibition boosts PFS over targeted agents alone Apr 27, 2020
<ѻý>Add-On Metformin No Help in Advanced Endometrial Cancerѻý> Trial highlights deep racial disparities in treatment response, survival outcomes Apr 27, 2020
<ѻý>Hormone Levels Tied to Future Breast Cancer Riskѻý> "New avenues for exploration" in risk stratification Apr 24, 2020
<ѻý>Herceptin Boosts OS in HER2-Positive Uterine Cancerѻý> New data bolster targeted approach for aggressive tumor type Apr 24, 2020
<ѻý>New Standard in Recurrent, Platinum-Sensitive Ovarian Cancerѻý> Pegylated liposomal doxorubicin unseats gemcitabine in standard platinum regimen Apr 21, 2020
<ѻý>Breastfeeding Tied to Lower Ovarian Cancer Riskѻý> Lower incidence of borderline tumors as well Apr 02, 2020
<ѻý>Blood Test Spot On for HPV Cancer Recurrenceѻý> Near-100% accuracy for ruling in or out recurrent oropharyngeal cancer Apr 01, 2020
<ѻý>How Prevalent Is Checkpoint Inhibitor Thyroid Dysfunction, Really?ѻý> Real-world data offer word of caution for oncologists Apr 01, 2020
<ѻý>Post-Op HPV Vaccine Cuts Cervical Precancer Recurrencesѻý> Plus osteoporosis in gynecologic cancer survivors, and a novel approach to CIN2/3 Mar 31, 2020
<ѻý>DOAC Works in Cancer-Related VTE, No Tradeoff in Bleedsѻý> Apixaban monotherapy matches dalteparin in non-inferiority trial Mar 29, 2020
<ѻý>Study: Any Polyps Raise Risk of Colorectal Cancerѻý> Only three types, however, increased mortality Mar 23, 2020
<ѻý>CRC: Upfront, Re-Introduction of FOLFOXIRI Most Effective, but at What Cost?ѻý> Modest survival improvement comes with side effects, toxicity even in healthiest patients Mar 13, 2020
<ѻý>Beyond CDK4/6 Inhibitors for HR-Positive Breast Cancerѻý> Switching drugs, taking aim at different targets under investigation Mar 11, 2020
<ѻý>No DNA Damage Seen With Single Low-Dose CT Scanѻý> Some reassurance for annual lung cancer screening safety Mar 10, 2020
<ѻý>James Lipton Dies of Bladder Cancerѻý> Delving into the iconic interviewer's condition Mar 09, 2020
<ѻý>Immunotherapy Super-Responder: What Is Life, Not Exactly Cured?ѻý> Lisa Geller's cancer has been gone nearly 4 years, but life has been far from normal Mar 02, 2020
<ѻý>Bringing Transplant to More Patients With AMLѻý> Conditioning with radiolabeled antibody leads to successful transplantation in 84% of older patients Feb 25, 2020